Pradžia › Narkolepsija › Ohio
Narkolepsija klinikiniai tyrimai Ohio
7 tyrimai dėl Narkolepsija ieško dalyvių vietose Ohio.
Miestai Ohio
Oficialus tyrimo tekstas (anglų kalba)
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Cincinnati, Ohio, Cincinnati
- Dublin, Ohio, Dublin
Renkami dalyviai2/3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07598708A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Cincinnati
Renkami dalyviai3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07455383A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- Intrepid Research, LLC, Cincinnati
- The Cleveland Clinic Foundation, Cleveland
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-27 · NCT07675135A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
- Intrepid Research, Cincinnati
- Ohio Sleep Medicine and Neuroscience Institute, Dublin
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-19 · NCT07625280A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Canton
- Alkermes Investigational Site, Cincinnati
- Alkermes Investigational Site, Cincinnati
- ir dar 1
Renkami dalyviai2/3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-08-07 · NCT06767683A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)
- Takeda Site 13, Cincinnati
Renkami dalyviai2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-06-29 · NCT07633301A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Cincinnati, Ohio, Cincinnati
- Dublin, Dublin
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-04-16 · NCT07096674Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.